2018
DOI: 10.1186/s12885-017-3892-2
|View full text |Cite
|
Sign up to set email alerts
|

Feasibility and acceptability of combining cognitive behavioural therapy techniques with swallowing therapy in head and neck cancer dysphagia

Abstract: BackgroundHead and neck cancer squamous cell carcinoma (HNSSC) patients report substantial rates of clinically significant depression and/or anxiety, with dysphagia being a predictor of distress and poorer quality of life. Evidence-based dysphagia interventions largely focus on the remediation of physical impairment. This feasibility study evaluates an intervention which simultaneously uses a psychological therapy approach combined with swallowing impairment rehabilitation.MethodsThis prospective single cohort… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
256
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 281 publications
(261 citation statements)
references
References 24 publications
4
256
1
Order By: Relevance
“…All the analyses were done at least in triplicates. For the statistical analyses the Dunnett’s multiple comparison tests, one-way ANOVA and Student’s t test on GraphPad Prism 6 [ 62 ] were used.…”
Section: Methodsmentioning
confidence: 99%
“…All the analyses were done at least in triplicates. For the statistical analyses the Dunnett’s multiple comparison tests, one-way ANOVA and Student’s t test on GraphPad Prism 6 [ 62 ] were used.…”
Section: Methodsmentioning
confidence: 99%
“…On the other hand, if patients are in an advanced disease phase (BP) or CML-CP (with T315I mutation), third-generation ponatinib is preferred over imatinib. 99 – 103 However, allo-HSCT remains a therapeutic option for patients in CML-CP whose CML has progressed after at least two TKIs and after trialing ponatinib therapy (for T315I mutation) to reduce the CML burden, and for the effectiveness of the transplantation. 99 , 100 , 102 An improvement in immunologic tolerance and lowered GVHD effect mean allo-HSCT is the only curative treatment option for CML-BP 104 ( Figure 2 ).…”
Section: Hematopoietic Stem-cell Transplantation To Treat Leukemiamentioning
confidence: 99%
“…Mathematical models have been developed to study many facets of GBM growth and response to treatment [5,22,[31][32][33][34][35][36][37][38][39][40][41][42][43]. There have been numerous papers published by Swanson et al demonstrating the clinical use of a relatively simple partial differential equation model Coupling multiscale data to a multiscale mathematical model.…”
Section: Introductionmentioning
confidence: 99%